Predictive Oncology Inc. — Director's Dealing 2012

Nov 8, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioDrain Medical, Inc. (BIOR)
CIK: 0001446159
Period of Report: 2012-11-06

Reporting Person: Herschkowitz Samuel (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-06	Common Stock, par value $0.01 per share	J	1031216	—	Acquired	46113986	Direct
2012-11-06	Common Stock, par value $0.01 per share	J	265608	—	Disposed	45848378	Direct

Footnotes

F1: On November 6, 2012, Dr. Herschkowitz entered into four Note Purchase Agreements (the "Note Purchase Agreements") with the Issuer, pursuant to which Dr. Herschkowitz advanced an aggregate of $156,243 to the Issuer. Under such Note Purchase Agreements, Dr. Herschkowitz was entitled to receive an aggregate of 1,031,216 shares of Common Stock, par value $0.01 per share, of the Issuer ("Shares") as an equity bonus.

F2: Immediately following the execution of the Note Purchase Agreements, Dr. Herschkowitz assigned three of the Note Purchase Agreements (including the right to receive any equity bonus thereunder), representing aggregate advances to the Issuer of $106,243 and entitling the assignees thereof to receive equity bonuses of 265,608 Shares, to three assignees unrelated to Dr. Herschkowitz. The aggregate consideration paid to Dr. Herschkowitz by such assignees was the aggregate principal amount of the promissory notes issuable under the Note Purchase Agreements, or $106,243.